TR200103285T2 - Projesteron reseptörü modülatörleri olarak siklokarbamat türevleri. - Google Patents

Projesteron reseptörü modülatörleri olarak siklokarbamat türevleri.

Info

Publication number
TR200103285T2
TR200103285T2 TR2001/03285T TR200103285T TR200103285T2 TR 200103285 T2 TR200103285 T2 TR 200103285T2 TR 2001/03285 T TR2001/03285 T TR 2001/03285T TR 200103285 T TR200103285 T TR 200103285T TR 200103285 T2 TR200103285 T2 TR 200103285T2
Authority
TR
Turkey
Prior art keywords
progesterone receptor
receptor modulators
ovum
prevention
treatment
Prior art date
Application number
TR2001/03285T
Other languages
English (en)
Turkish (tr)
Inventor
Zhang Puwen
Fensome Andrew
A. Terefenko Eugene
E. Wrobel Jay
A. Collins Mark
Zhi Lin
K. Jones Todd
M. Tegley Christopher
P. Edwards James
Original Assignee
American Home Products Corporation
Ligand Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,354 external-priority patent/US6436929B1/en
Application filed by American Home Products Corporation, Ligand Pharmaceuticals, Inc. filed Critical American Home Products Corporation
Publication of TR200103285T2 publication Critical patent/TR200103285T2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Detergent Compositions (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TR2001/03285T 1999-05-04 2000-05-01 Projesteron reseptörü modülatörleri olarak siklokarbamat türevleri. TR200103285T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18301399P 1999-05-04 1999-05-04
US09/552,354 US6436929B1 (en) 1999-05-04 2000-04-19 Cyclothiocarbamate derivatives as progesterone receptor modulators

Publications (1)

Publication Number Publication Date
TR200103285T2 true TR200103285T2 (tr) 2002-02-21

Family

ID=26878649

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/03285T TR200103285T2 (tr) 1999-05-04 2000-05-01 Projesteron reseptörü modülatörleri olarak siklokarbamat türevleri.

Country Status (24)

Country Link
EP (1) EP1175411B1 (cg-RX-API-DMAC10.html)
JP (2) JP4958338B2 (cg-RX-API-DMAC10.html)
KR (1) KR100732692B1 (cg-RX-API-DMAC10.html)
CN (1) CN1131856C (cg-RX-API-DMAC10.html)
AT (1) ATE386729T1 (cg-RX-API-DMAC10.html)
AU (1) AU766801B2 (cg-RX-API-DMAC10.html)
BG (1) BG65277B1 (cg-RX-API-DMAC10.html)
BR (1) BR0010214A (cg-RX-API-DMAC10.html)
CA (1) CA2371712C (cg-RX-API-DMAC10.html)
CZ (1) CZ20013952A3 (cg-RX-API-DMAC10.html)
DE (1) DE60038108T2 (cg-RX-API-DMAC10.html)
DK (1) DK1175411T3 (cg-RX-API-DMAC10.html)
EA (1) EA004511B1 (cg-RX-API-DMAC10.html)
ES (1) ES2301482T3 (cg-RX-API-DMAC10.html)
GE (1) GEP20043181B (cg-RX-API-DMAC10.html)
HU (1) HUP0203332A3 (cg-RX-API-DMAC10.html)
IL (1) IL146298A0 (cg-RX-API-DMAC10.html)
MX (1) MXPA01011287A (cg-RX-API-DMAC10.html)
NO (1) NO321370B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ515353A (cg-RX-API-DMAC10.html)
PL (1) PL351083A1 (cg-RX-API-DMAC10.html)
SG (1) SG120970A1 (cg-RX-API-DMAC10.html)
SK (1) SK15922001A3 (cg-RX-API-DMAC10.html)
TR (1) TR200103285T2 (cg-RX-API-DMAC10.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407101B1 (en) * 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
KR100732692B1 (ko) * 1999-05-04 2007-06-27 와이어쓰 프로게스테론 수용체 조절인자인 시클로티오카르바메이트유도체
JP4950027B2 (ja) * 2004-04-08 2012-06-13 ワイス・エルエルシー チオアミド不純物を最小限に抑えるための方法
EP1732921B1 (en) * 2004-04-08 2008-11-05 Wyeth Thioamide derivatives as progesterone receptor modulators
BRPI0510260A (pt) * 2004-04-27 2007-10-23 Wyeth Corp método para purificar um composto, e, kit farmacêutico
JP5108506B2 (ja) * 2004-04-27 2012-12-26 ワイス・エルエルシー シアノピロール含有環式カルバメートおよびチオカルバメートビアリール、およびこれらの製造方法
AR049707A1 (es) * 2004-07-07 2006-08-30 Wyeth Corp Regimenes y kits de progestina ciclica
AU2005272854B2 (en) * 2004-08-13 2012-04-26 Wyeth Tanaproget derivatives, metabolites, and uses thereof
BRPI0610438A2 (pt) 2005-04-28 2012-10-23 Wyeth Corp composição farmacêutica, cápsula, conjunto farmacêutico, e, processo para preparar uma composição
US7767668B2 (en) * 2005-04-28 2010-08-03 Wyeth Llc Micronized tanaproget, compositions, and methods of preparing the same
ES2431324T3 (es) * 2005-04-28 2013-11-26 Wyeth Llc Forma purificada de tanaproget
WO2006116596A2 (en) * 2005-04-28 2006-11-02 Wyeth Micronized tanaproget and compostions containing same
MX2007013469A (es) * 2005-04-28 2008-01-22 Wyeth Corp Forma ii polimorfa de tanaproget.
MX2007015571A (es) * 2005-06-09 2008-03-06 Wyeth Corp Composiciones de tanaproget que contienen etinilestradiol.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510235A1 (en) * 1991-04-26 1992-10-28 Dong-A Pharm. Co., Ltd. Novel benzoxazine or benzothiazine derivatives and process for the preparation of the same
JPH0510235A (ja) * 1991-07-05 1993-01-19 Nippondenso Co Ltd 内燃機関の点火時期制御装置
WO1995020389A1 (en) * 1994-01-28 1995-08-03 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
US5688808A (en) * 1994-12-22 1997-11-18 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
AU717251B2 (en) * 1994-12-22 2000-03-23 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
DE69724630T2 (de) * 1996-10-02 2004-07-29 Bristol-Myers Squibb Pharma Co. 4,4-disubstituierte 1,4-dihydro-2h-3,1-benzoxazin-2-one die anwendbar sind als hiv-reverstranskriptase-inhibitoren, zwischenprodukte und verfahren zu ihrer herstellung
KR100732692B1 (ko) * 1999-05-04 2007-06-27 와이어쓰 프로게스테론 수용체 조절인자인 시클로티오카르바메이트유도체
WO2006116596A2 (en) * 2005-04-28 2006-11-02 Wyeth Micronized tanaproget and compostions containing same
MX2007015571A (es) * 2005-06-09 2008-03-06 Wyeth Corp Composiciones de tanaproget que contienen etinilestradiol.

Also Published As

Publication number Publication date
GEP20043181B (en) 2004-02-25
SK15922001A3 (sk) 2002-09-10
PL351083A1 (en) 2003-03-10
IL146298A0 (en) 2002-07-25
HUP0203332A2 (hu) 2003-01-28
JP2002543192A (ja) 2002-12-17
JP5523430B2 (ja) 2014-06-18
EA200101181A1 (ru) 2002-04-25
DK1175411T3 (da) 2008-06-09
NO20015381D0 (no) 2001-11-02
KR20020000170A (ko) 2002-01-04
NO20015381L (no) 2002-01-03
AU766801B2 (en) 2003-10-23
CA2371712C (en) 2009-12-22
DE60038108D1 (de) 2008-04-03
SG120970A1 (en) 2006-04-26
NO321370B1 (no) 2006-05-02
DE60038108T2 (de) 2009-02-12
JP4958338B2 (ja) 2012-06-20
EP1175411A1 (en) 2002-01-30
EA004511B1 (ru) 2004-04-29
JP2012087129A (ja) 2012-05-10
MXPA01011287A (es) 2003-07-14
ES2301482T3 (es) 2008-07-01
KR100732692B1 (ko) 2007-06-27
CZ20013952A3 (cs) 2002-05-15
BG106080A (en) 2002-05-31
AU4811900A (en) 2000-11-17
EP1175411B1 (en) 2008-02-20
BG65277B1 (bg) 2007-11-30
NZ515353A (en) 2004-03-26
CA2371712A1 (en) 2000-11-09
HUP0203332A3 (en) 2004-12-28
CN1131856C (zh) 2003-12-24
CN1349516A (zh) 2002-05-15
BR0010214A (pt) 2002-02-13
ATE386729T1 (de) 2008-03-15

Similar Documents

Publication Publication Date Title
NO964155L (no) Progesteronantagonister for fremstilling av legemidler til behandling av dysfunksjonelle uterusblödninger
DE60035496D1 (de) Indolinderivate als progesteron antagonisten
TR200000015T2 (tr) Bileşikler ve metodlar
TR200100149T2 (tr) Dual anjiyotensin endotelin alıcı antagonistleri olarak bifenil-sülfonamitler
CY1121926T1 (el) (11.βητα., 17.βητα.)-17-υδροξυ-11-[4(μεθυλοσουλφονυλο)φαινυλο]-17-(πενταφθορομεθυλο)οιστρα-4,9-διεν-3-ονη για την αγωγη παθησεων
AR079350A1 (es) Anticuerpos neutralizadores contra el receptor de prolactina y su uso terapeutico
TW200607798A (en) Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof
MX9700534A (es) Uso de droloxifeno y sus sales farmaceuticamente aceptables en la preparacion de remedios para tratar las enfermedades de prostata, endometriosis y obesidad.
NO20010446L (no) Substituert anilidforbindelser og metoder
BR0316843A (pt) Derivados tetracìclicos contendo heteroátomo como moduladores seletivos do receptor de estrogênio
TR200200066T2 (tr) Migrenin tedavisi için seçici iGluR5 reseptör antagonistleri
TR200102107T2 (tr) Tümör nekroz faktör antagonistleri ve endometriozda kullanımları.
EP1877059B8 (en) Micronized tanaproget and compostions containing same
NZ515353A (en) Cyclothiocarbamate derivatives as progesterone receptor modulators
DE602005019905D1 (de) -modulatoren
WO2002056903A3 (en) Methods for treating hormone associated conditions using a combination of lhrh antagonists and specific estrogen receptor modulators
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
CL2003001544A1 (es) Compuestos derivados de 5-cicloalquenil-5h-cromeno[3,4-f]quinolina de formula i, moduladores selectivos del receptor de progesterona; composicion farmaceutica; y su uso en el tratamiento de sangrado uterino disfuncional, dismenorrea, endometriosis, l
MX2009009514A (es) Heterociclos sulfonilados utiles para la modulacion del receptor de progesterona.
ATE412631T1 (de) Indolderivate als progesteron-rezeptormodulatoren
DE60032333D1 (de) Zusammensetzungen und verfahren zur intraductalen gentherapie
TR200102781T2 (tr) Yeni bileşikler
TR200103288T2 (tr) Tio-oksindol türevleri
WO2008109055A8 (en) Cyanopyrrole sulfonamides useful for modulation of the progesterone receptor
ATE298244T1 (de) Monoklonaler antikörper mit selektiver bindung an vgf und verwendung zur behandlung von vgf- erkrankungen